BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25592951)

  • 1. [Quality and safety of Chinese medicine drugs in Germany - an update].
    Hempen N; Huber R
    Forsch Komplementmed; 2014; 21(6):401-12. PubMed ID: 25592951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.
    Melchart D; Hager S; Dai J; Weidenhammer W
    Forsch Komplementmed; 2016; 23 Suppl 2():21-8. PubMed ID: 27272353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and application of "multi-dimensional structure and process dynamic quality control technology system" in preparation products of traditional Chinese medicine (I)].
    Gu JF; Feng L; Zhang MH; Wu C; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3613-7. PubMed ID: 24494541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of Chinese herbal pieces and analysis of problems of total quality management].
    Wang J; Qiao XY; Lin F; Chen YF
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4475-8. PubMed ID: 25850288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of quality traceability system of traditional Chinese medicine].
    Cai Y; Hu H; Ni JY; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
    Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.
    Dobos GJ; Tan L; Cohen MH; McIntyre M; Bauer R; Li X; Bensoussan A
    Complement Ther Med; 2005 Sep; 13(3):183-90. PubMed ID: 16150372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.
    Koh HL; Woo SO
    Drug Saf; 2000 Nov; 23(5):351-62. PubMed ID: 11085343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
    Wang LX; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic heavy metals and undeclared drugs in Asian herbal medicines.
    Ernst E
    Trends Pharmacol Sci; 2002 Mar; 23(3):136-9. PubMed ID: 11879681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicological risks of Chinese herbs.
    Shaw D
    Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the baseline contents and reference maximum limit standard of heavy metals and harmful element of 23 Chinese herbs in Northern China].
    Li XW; Gao JQ; Zhao JL; Chen JM
    Wei Sheng Yan Jiu; 2006 Jul; 35(4):459-63, 467. PubMed ID: 16986524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application status and safety countermeasures of traditional Chinese medicine injections].
    Xiong XJ; Wang J; He QY
    Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):307-11. PubMed ID: 20388469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some aspects of toxic contaminants in herbal medicines.
    Chan K
    Chemosphere; 2003 Sep; 52(9):1361-71. PubMed ID: 12867165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems in quality standard research of new traditional Chinese medicine compound].
    Zhou G; He YP
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3389-91. PubMed ID: 25522635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.